Megan McCormick brings over 28 years of experience in clinical research and biopharmaceutical development to her role as Chief Operating Officer at ProSciento. She previously served as Vice President of Development Operations at PPD, where she led global clinical teams and strategic initiatives across multiple therapeutic areas. Prior to her 23-year tenure in leadership roles at PPD, Megan held field-based CRA and clinical program management roles at Eli Lilly and AstraZeneca, providing her with a deep hands-on understanding of clinical project management and operational delivery. Megan is further recognized for her passion for mentoring and building high-performing teams that deliver operational excellence in complex trial environments.
